Filbrandt Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-75
Closed -$13K 196
2020
Q4
$13K Buy
+75
New +$11.2K 0.01% 127
2020
Q3
Sell
-354
Closed -$58K 264
2020
Q2
$58K Buy
+354
New +$54.3K 0.05% 103
2020
Q1
Sell
-518
Closed -$68K 289
2019
Q4
$68K Buy
+518
New +$60K 0.06% 67

Other funds holding LLY

Filbrandt Wealth Management's LLY Position: Q1 2021 in Review

Filbrandt Wealth Management sold out of Eli Lilly (LLY) in Q1 2021, closing a stake of 75 shares — an estimated $13K sold.

Filbrandt Wealth Management first reported a position in LLY in Q4 2019 and held it in 3 quarters. The position peaked at $68K in Q4 2019. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.

  • Filbrandt Wealth Management reported no remaining Eli Lilly position as of Q1 2021 after selling out during the quarter.
  • Filbrandt Wealth Management sold 75 Eli Lilly shares in Q1 2021, an estimated $13K.
  • Filbrandt Wealth Management first reported a position in Eli Lilly in Q4 2019 and held it in 3 quarters.
  • Filbrandt Wealth Management's Eli Lilly position peaked at $68K in Q4 2019.
  • 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.

Based on Filbrandt Wealth Management's 13F filing for Q1 2021, filed 21 Apr 2021.